Has anyone seen a press release from Lincoln Park Capital that they have in fact bought any shares of ZLCS?
I would strongly suggest that you people do some DD into exactly what LPC has done recently, and how their other commitments have been doing.
Just food for thought............
"We have the right to terminate the Purchase Agreement at any time, at no cost or penalty. From the effective date of the purchase agreement through June 30, 2013, we have issued an aggregate of 6,104,147 shares of common stock to LPC, including the 800,000 shares of common stock issued to LPC as consideration for entering into the purchase agreement, under the purchase agreement for gross proceeds of approximately $3.2 million. Between July 1, 2013 and August 5, 2013, we issued an additional 1,500,000 shares of common stock to LPC under the Purchase Agreement for additional gross proceeds of approximately $0.7 million. On a cumulative basis, from the effective date of the purchase agreement through August 5, 2013, we have issued a total of 7,604,147 shares of common stock to LPC, including the 800,000 shares of common stock issued to LPC as consideration for entering into the purchase agreement, for aggregate gross proceeds of $3.9
---- Directly from the 10Q, can’t get more of a positive answer than that. LPC has been buying!
they bash when things are bad and bought at the low when things are good. Truth is:
Stock Price at .595
Reverse split on the table
Quarterly report says things are on track
Cash burn at least into 2014
Lincoln Park Capital willing to invest $25 Million
Exalgo – On the Market being sold – Z Collecting Royalities
CHTS Program – Renewed with Novartis - Growing year over year
Prednisporin – In Sanofi’s hands looking for a sublicense partner – Phase 3 brings $3M to Z.
Z160 – 2 Phase 2a results due by the End Of Year.
Z944 – Slated to start the 1B trail Q3 and 1B results in Q4.
The people that have done their homework know this. There’s upside into Oct and its been proven two days can cause a substantial run for this stock. The price here is worth the admission at least until before the Z160 results are released.
Rhino: I totally agree. Let the facts speak for themselves. I doubt that there are many small Bio's that can claim that their in a similarly positive situation.
Syn came at a bad time, not that I disagree with managements decision, just bad timing. Then the Daug tossed in a bold faced lie and the "Brains" of SA bought it and the damage was done. If not for those 2 incidents I think we'd be hovering around $1.60 and waiting for Oct. with baited breath.
I'm not much on predictions but I honestly feel we will be staring $3.00 to $4.00 in the face by years end, it all depends on the Z-160 results. One other prediction, if the trial comes in good they will file for Orphan Drug Status pronto.
Jim Long and calm
Sentiment: Strong Buy
May I ask why buy now? I am in big loss, simply because I believe pain remedy has potential, especially for cancer patients. Bought at .78, down to .59, why? Is this company dead? Can't even be bought out? Thank you.
Why? To test your resolve....to shake out and scare the little children into releasing more stock that the more informed seek to buy at lower prices. If you care about these penny price swings when the future of pain management is at stake...you need to pucker up to the bar....or just sell out like the children.